Patent details

Basic Information

Publication number:

EP3375454

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181558867

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English Title of Invention:

RNA COMPOSITION FOR TREATING NON-SMALL LUNG CANCER (NSCLC)

French Title of Invention:

COMPOSITION D'ARN POUR LE TRAITEMENT DU CANCER DU POUMON NON À PETITES CELLULES (NSCLC)

German Title of Invention:

RNA-ZUSAMMENSETZUNG ZUR BEHANDLUNG VON NICHT-KLEINZELLIGEM LUNGENKREBS (NSCLC)

SPC Number:

Dates

Filing date:

08/10/2008

Grant date:

14/04/2021

EP Publication Date:

19/09/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/04/2021

EP B1 Publication Date:

14/04/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/10/2021

Expiration date:

08/10/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/04/2021

 

 

Name:

CureVac AG

Address:

Friedrich-Miescher-Straße 15, 72076 Tübingen, Germany (DE)

Inventor

1

Name:

Hoerr, Ingmar

Address:

Germany (DE)

2

Name:

Lander, Thomas

Address:

Germany (DE)

3

Name:

Barner, Marijke

Address:

Germany (DE)

4

Name:

Probst, Jochen

Address:

Germany (DE)

Priority

Priority Number:

PCT/EP2007/008770

Priority Date:

09/10/2007

Priority Country:

World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:

A61K 39/00; C12N 15/12; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202115

Publication date:

14/04/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages